Barclays’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.9M | Buy |
254,870
+110,095
| +76% | +$1.25M | ﹤0.01% | 1981 |
|
|
2025
Q1 | $1.72M | Sell |
144,775
-4,561
| -3% | -$54.2K | ﹤0.01% | 2119 |
|
|
2024
Q4 | $2.81M | Buy |
149,336
+20,992
| +16% | +$396K | ﹤0.01% | 1998 |
|
|
2024
Q3 | $2.88M | Buy |
128,344
+56,190
| +78% | +$1.26M | ﹤0.01% | 1913 |
|
|
2024
Q2 | $1.51M | Buy |
72,154
+24,639
| +52% | +$514K | ﹤0.01% | 1883 |
|
|
2024
Q1 | $698K | Sell |
47,515
-21,224
| -31% | -$312K | ﹤0.01% | 2637 |
|
|
2023
Q4 | $709K | Buy |
68,739
+1,272
| +2% | +$13.1K | ﹤0.01% | 2813 |
|
|
2023
Q3 | $530K | Sell |
67,467
-1,524
| -2% | -$12K | ﹤0.01% | 2516 |
|
|
2023
Q2 | $690K | Sell |
68,991
-3,156
| -4% | -$31.6K | ﹤0.01% | 2402 |
|
|
2023
Q1 | $642K | Sell |
72,147
-27,510
| -28% | -$245K | ﹤0.01% | 2462 |
|
|
2022
Q4 | $1.09M | Buy |
99,657
+15,166
| +18% | +$166K | ﹤0.01% | 2054 |
|
|
2022
Q3 | $1.1M | Buy |
84,491
+81,760
| +2,994% | +$1.07M | ﹤0.01% | 2059 |
|
|
2022
Q2 | $34K | Sell |
2,731
-2,448
| -47% | -$30.5K | ﹤0.01% | 3888 |
|
|
2022
Q1 | $72K | Buy |
+5,179
| New | +$72K | ﹤0.01% | 3827 |
|